Gene · 6391
Papers4,029
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
221 to 240 of 4,029
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| De novo dedifferentiated SDH-deficient gastrointestinal stromal tumor with MDM2 amplification: case report and literature review. | Front Oncol | 2023 | 37781202 | PubTator, text mining | PubMed |
| A DNA Plasmid-Based Approach for Efficient Synthesis of Sacbrood Virus Infectious Clones within Host Cells. | Viruses | 2023 | 37766273 | PubTator, text mining | PubMed |
| Mixed Corticomedullary Tumor of the Adrenal Gland: A Case Report and Literature Review. | Medicina (Kaunas) | 2023 | 37763658 | PubTator, text mining | PubMed |
| Ginsenoside F1-Mediated Telomere Preservation Delays Cellular Senescence. | Int J Mol Sci | 2023 | 37762556 | PubTator, text mining | PubMed |
| A Laboratory Medicine Perspective on the Investigation of Phaeochromocytoma and Paraganglioma. | Diagnostics (Basel) | 2023 | 37761307 | PubTator, text mining | PubMed |
| Image-Guided Precision Medicine in the Diagnosis and Treatment of Pheochromocytomas and Paragangliomas. | Cancers (Basel) | 2023 | 37760633 | PubTator, text mining | PubMed |
| Data Mining of Microarray Datasets in Translational Neuroscience. | Brain Sci | 2023 | 37759919 | PubTator, text mining | PubMed |
| Spontaneous Confinement of mRNA Molecules at Biomolecular Condensate Boundaries. | Cells | 2023 | 37759470 | PubTator, text mining | PubMed |
| Identification of potential molecular targets for the treatment of cluster 1 human pheochromocytoma and paraganglioma via comprehensive proteomic characterization. | Clin Proteomics | 2023 | 37749499 | PubTator, text mining | PubMed |
| Periodontal Ligament Stem Cell Exosomes Key to Regulate Periodontal Regeneration by miR-31-5p in Mice Model. | Int J Nanomedicine | 2023 | 37746047 | PubTator, text mining | PubMed |
| The role of bone marrow microenvironment (BMM) cells in acute myeloid leukemia (AML) progression: immune checkpoints, metabolic checkpoints, and signaling pathways. | Cell Commun Signal | 2023 | 37735675 | PubTator, text mining | PubMed |
| Acute myeloid leukemia-derived exosomes deliver miR-24-3p to hinder the T-cell immune response through DENN/MADD targeting in the NF-κB signaling pathways. | Cell Commun Signal | 2023 | 37735672 | PubTator, text mining | PubMed |
| Pheochromocytoma: A Troublesome Tumor. | Cureus | 2023 | 37727845 | PubTator, text mining | PubMed |
| Divergent single cell transcriptome and epigenome alterations in ALS and FTD patients with C9orf72 mutation. | Nat Commun | 2023 | 37714849 | PubTator, text mining | PubMed |
| KLF5 Promotes Tumor Progression and Parp Inhibitor Resistance in Ovarian Cancer. | Adv Sci (Weinh) | 2023 | 37702443 | PubTator, text mining | PubMed |
| Expression and function of CCN2-derived circRNAs in chondrocytes. | J Cell Commun Signal | 2023 | 37695440 | PubTator, text mining | PubMed |
| Advancing precision oncology through systematic germline and tumor genetic analysis: The oncogenetic point of view on findings from a prospective multicenter clinical trial of 666 patients. | Cancer Med | 2023 | 37694493 | PubTator, text mining | PubMed |
| Lipid scrambling is a general feature of protein insertases. | bioRxiv | 2023 | 37693532 | PubTator, text mining | PubMed |
Cyclin dependent kinase inhibitor 3 (CDKN3) upregulation is associated with unfavorable prognosis in clear cell renal cell carcinoma and shapes tumor immune microenvironment: A bioinformatics analysis. | Medicine (Baltimore) | 2023 | 37682177 | PubTator, text mining | PubMed |
| Mitochondria in the Spotlight: C. elegans as a Model Organism to Evaluate Xenobiotic-Induced Dysfunction. | Cells | 2023 | 37681856 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/6391/papers?page=12